1-3 of 3
Karin Hohloch, MD
Close
Sort by
Journal Articles

Treatment of Early Stage Nodal Follicular Lymphoma Using Involved-Field Radiotherapy and Rituximab: Preliminary Results of the Mir Trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG))

Klaus Herfarth, MD, Marianne Engelhard, MD, Peter Borchmann, MD, Karin Hohloch, MD, Volker Budach, MD, Andreas Viardot, MD, Mathias Witzens-Harig, MD, Hans Eich, MD, Wolfgang Hiddemann, MD, PhD, Martin Dreyling
Journal: Blood
Blood (2012) 120 (21): 1634.
https://doi.org/10.1182/blood.V120.21.1634.1634
Published: 2012
Journal Articles

MERIT Study – “Multicenter Evaluation of Patient- and Lesion-Specific Prognostic Factors for RadioImmunoTherapy with 90 yttrium-Labeled Anti-CD20 in Follicular Non-Hodgkin's lymphoma”.

Aleksandar Grgic, MD, Ursula Nestle, MD, PhD, Elena Ballek, MD, Klemens Scheidhauer, MD, PhD, Cornelia Puskas, MD, Jochem Koenig, PhD, Karin Hohloch, MD, Joerg Schubert, MD, Lorenz H. Truemper, Carl-Martin Kirsch, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4792.
https://doi.org/10.1182/blood.V114.22.4792.4792
Published: 2009
Journal Articles

Radioimmunotherapy Is Safe and Effective in Relapse after Stem Cell Transplantation for B- Cell Non Hodgkins Lymphoma, An Analysis of the International RIT-Network

Karin Hohloch, MD, P.L. Zinzani, M.D., Werner Linkesch, Jr., Andrzej Deptala, MD, PhD, Jurczak Wojciech, Cheolwon Suh, Michael Lorsbach, Christiane Windemuth-Kiesselbach, Lorenz H. Truemper
Journal: Blood
Blood (2008) 112 (11): 3064.
https://doi.org/10.1182/blood.V112.11.3064.3064
Published: 2008